Summary Latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Pipeline Review, H1 2020, provides an overview of the Retinoblastoma (Oncology) pipeline landscape.
Treatment includes chemotherapy, radiation therapy and surgery.
Report Highlights We are Pharmaceutical and Healthcare latest pipeline guide Retinoblastoma - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Retinoblastoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed and Preclinical stages are 3, 2, 1 and 6 respectively.
Retinoblastoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.